Delivery Order SPE2DB22D1106-SPE2DB24FEEE9
- Not listed
- The Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract valued at $9,550.17 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This contract is for the supply of RINVOQ ER 15 MG TABLET, a specialty pharmaceutical product, to support military treatment programs and facilities. The contract has a completion date of March 1, 2024. Amerisourcebergen Drug Corp is...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $6,015.42 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The contract is for the delivery of RINVOQ ER 15 MG TABLET UU 30S, a specialty pharmaceutical product, with a period of performance through March 6, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $6,863.94 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 45 MG TABLET UU 28S. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract, valued at $7,275.16, to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of the pharmaceutical product RINVOQ ER 30 MG TABLET UU 30S. The contract has a period of performance through March 12, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a separate $999,999,999.00 indefinite delivery contract (IDC) awarded by DLA, which serves as the...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $26,163.08 firm-fixed-price delivery order contract to Amerisource Bergen Drug Corporation's Corporate Office division. The contract is for the supply of RINVOQ ER 30 MG TABLET, a pharmaceutical product, with a period of performance through September 13, 2024. This contract award is under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between the DLA Troop Support Medical and Amerisource Bergen,...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $12,084.60 contract is for the delivery of RINVOQ ER 15 MG TABLET, a specialty pharmaceutical product, with a performance period through April 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with...
- The Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $7,463.05 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Rinvoq ER 15 mg tablet. This delivery order contract supports DLA Troop Support Medical in supplying pharmaceuticals and medical supplies to military treatment programs and facilities. Amerisourcebergen Drug Corp is also the prime contractor on a $999,999,999.00 indefinite...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, to provide RINVOQ ER 30 MG TABLET UU 30S. The contract has a potential value of $16,973.25 and a performance period through January 29, 2024. Amerisourcebergen Drug Corporation is the prime contractor, with no set-aside designation indicated. This delivery order is issued under a larger indefinite...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product RINVOQ ER 15 MG TABLET UU 30S. The contract has a completion date of February 22, 2024 and a potential value of $12,030.84. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation for this award. The contract was issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,983.60 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 4564110483 RINVOQ ER 30 MG TABLET UU 30S. This order falls under a larger $999,999,999.00 indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp to supply pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEEE9Delivery Order
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $7,492.61 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of RINVOQ ER 15 MG TABLET pharmaceutical products. The contract has a performance period through March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order, which is part of a larger indefinite delivery contract (IDC) the company holds with DLA Troop Support Medical with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. This IDC serves as the primary contract vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. No set-aside designation was used for this specific delivery order.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.5k | 3/11/24 |